课题基金 / 基金详情

IMMUNOLOGIC MEMORY FOLLOWING PNEUMOCOCCAL, HEP B, AND MEASLES VACCINATION P1061

IMMUNOLOGIC MEMORY FOLLOWING PNEUMOCOCCAL, HEP B, AND MEASLES VACCINATION P1061
肺炎球菌、乙型肝炎和麻疹疫苗接种后的免疫记忆 P1061
批准号:
7607895
负责人:
Sharon A Nachman
金额:
$0.4万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-23 至 2007-11-30

项目摘要

项目成果

Sharon A Nachman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This subject is eligible to participate in this substudy because they have participated in P1024, "Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Treated with Highly Active Antiretroviral Therapy (HAART)." P1024 was a study to see how well the following vaccines can help children fight different types of infection: Pneumococcal Conjugate Vaccine (PCV), Pneumococcal Polysaccharide Vaccine (PPV), Measles-Mumps-Rubella Vaccine (M-M-R¿II), Diphtheria-Tetanus-Pertussis Vaccine (DTaP) and Hepatitis B Vaccine (HBV). This substudy will look at whether or not the subject has developed "immunologic memory" from the vaccines received in P1024 . To see if they have developed protective cells that remember how to fight pneumococcal, measles, and hepatitis B infection). This substudy will check if they are still protected from the following: pneumococcal infection, measles, and/or hepatitis B virus. This substudy will not look at immunologic protection against pertussis. This substudy will look at whether the subject has developed protective cells that remember how to fight pneumococcal, measles, and hepatitis B infection by giving you/your child additional (booster) doses of Pneumococcal Conjugate Vaccine (PCV) or Pneumococcal Polysaccharide Vaccine (PPV); Measles-Mumps-Rubella Vaccine (M-M-R¿II); and Hepatitis B Vaccine (HBV) and looking at blood tests that test for responses to these vaccines. The child will not receive a booster dose of Diphtheria-Tetanus-Pertussis Vaccine (DTaP) as part of this substudy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the US
  • 批准号:
    10174121
  • 项目类别:
  • 资助金额:
    $94.26万
  • 财政年份:
    2020
  • 负责人:
    Sharon A Nachman
  • 依托单位:
SURVEILLANCE MONITORING FOR ART TOXICITIES
CLINICAL TRIAL: PHASE I/II STUDY OF SAFETY AND IMMUNOGENICITY OF QUADRIVALENT ME
CLINICAL TRIAL: PHASE I/II MULTICENTER,OPEN LABEL,NONCOMPARITIVE STUDY OF HIV AF
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: